Navigation Links
Alexza to Present at the MDB Bright Lights Conference 2011
Date:5/6/2011

ped for the rapid treatment of agitation in schizophrenic or bipolar disorder patients.  Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials and submitted the AZ-004 NDA in December 2009.  In October 2010, the Company received a Complete Response Letter, or CRL, from the FDA, regarding its NDA for AZ-004.  A CRL is issued by FDA's Center for Drug Evaluation and Research indicating that the NDA review cycle is complete and the application is not ready for approval in its present form.  The Company completed an end-of-review meeting with the FDA in late December 2010.

The Company believes it has a clear understanding of the issues outlined in the CRL, is developing and executing a plan to address these issues, and currently projects a resubmission of the AZ-004 NDA in July 2011.

For more information about Alexza, the Staccato technology or the Company's development programs, please visit www.alexza.com.

Safe Harbor Statement

The anticipated presentation will contain forward-looking statements that involve significant risks and uncertainties.  Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs, including the adequacy of the Company's capital to support the Company's current operations, the potential of the Company's planned AZ-004 NDA resubmission to adequately address the issues in the CRL, the eventual prospects that AZ-004 will be approved for marketing and the timing of the Company's resubmission of the AZ-004 NDA to the FDA.  The Company's forward-looking statements also involve assumptions tha
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... DUBLIN , March 30, 2015 Perrigo ... global provider of "Quality Affordable Healthcare Products®," today announced ... Pharma Invest N.V. ("Omega") in a cash and equity ... assumption of €1.3 billion in debt. Sellers are ... and co-investors of Waterland.    ...
(Date:3/30/2015)... , March 30, 2015 A team ... atomic structure of a cell-surface receptor that plays a ... research unexpectedly discloses many new structural features, which challenge ... receptors (GPCRs) and open a new door for future ... Nature on March 30, the researchers at ...
(Date:3/30/2015)... Research and Markets ( http://www.researchandmarkets.com/research/n6x9q9/marine ... "Marine Biotechnology - Global Strategic Business Report" ... and forecasts are provided for the period 2013 ... provided for these markets. Market data and analytics ... This report analyzes the worldwide markets for ...
Breaking Medicine Technology:Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 2Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 4Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 5New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 2New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 3New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 4New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 5New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 6Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 2Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 3Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 4Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 5Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 6Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 7
... Feb. 22, 2011 Proacta Incorporated and ... announced the execution of a definitive agreement ... commercialization of Proacta,s PR509, a hypoxia-activated pro-drug ... (Logo: http://photos.prnewswire.com/prnh/20110222/LA50556LOGO-a) (Logo: http://photos.prnewswire.com/prnh/20110222/LA50556LOGO-b) ...
... ALLEGAN, Mich., Feb. 22, 2011 Perrigo Company (Nasdaq: ... has filed an Abbreviated New Drug Application for calcipotriene ... of Taclonex® Ointment. Another generic company is the first ... and Betamethasone) ointment is indicated for the topical treatment ...
Cached Medicine Technology:Proacta Incorporated and Yakult Honsha Announce an Agreement for the Collaborative Research, Development and Commercialization for Proacta's PR509 Compound 2Proacta Incorporated and Yakult Honsha Announce an Agreement for the Collaborative Research, Development and Commercialization for Proacta's PR509 Compound 3Perrigo Confirms Filing for Generic Version of Taclonex® Ointment and Announcement of Lawsuit by Leo Pharma 2Perrigo Confirms Filing for Generic Version of Taclonex® Ointment and Announcement of Lawsuit by Leo Pharma 3
(Date:3/30/2015)... Murfreesboro, TN (PRWEB) March 30, 2015 Good ... in need. The Children’s Home in Murfreesboro provides a Christian-based ... the love of Christ and his special plan for their ... dawn of a new day begins as, one-by-one, the children ... Samantha’s day begins as the alarm continues to buzz. ...
(Date:3/30/2015)... Murfreesboro, TN (PRWEB) March 30, 2015 Dr. ... TN office. , The mini implant is placed into ... to be stabilized is fitted and snapped into place. For ... or talking, mini implants could be the solution. Thousands of ... right in place without any adhesives. It is all made ...
(Date:3/30/2015)... Dr. Jeffrey Allred DDS, with his practice based ... second opinion consultations for patients who need a second ... second opinions show how small percentage of dentistry patients go ... 6%” – says Dr. Allred. , “People should not ... the dental care provider, for the simple fact that every ...
(Date:3/30/2015)... The partners of Urgent Care of Westchester and ... Bella Diosa Laser Med Spa, offering the residents of ... spa treatments. , February marked the grand opening of ... the medical services provided by Urgent Care of Westchester ... for both women and men. , Conveniently located in ...
(Date:3/30/2015)... The fertility team at Ada ... asked questions to give intended parents across the globe ... , After unveiling the most affordable, non-sharing ... IVF clinic has witnessed an increase in fertility patients. ... provides attentive reproductive care — with all-inclusive IVF treatment ...
Breaking Medicine News(10 mins):Health News:Good Shepherd Children’s Home Announces 53rd Year of Providing a Safe-Haven for Children in Need 2Health News:Dr. Jeffrey Farmer A Murfreesboro Dentist Announces New High Tech Dentistry 2Health News:Allred Dental Offers Complimentary 15 Minute Consults with Dr. Jeffrey Allred in San Marcos, CA 2Health News:Yonkers Celebrates the Grand Opening of Bella Diosa 2Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 2Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 3Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 4
... Ind., Feb. 19 An error in the most ... Yellow Book directed Monroe,Hospital callers to an entirely different ... who expected to schedule their next,appointment instead found they ... to the hotline. , Both ...
... annual report on nation,s health focuses on those aged 18 ... rates of obesity and lack of insurance coverage are among ... just-released statistics. , A special section on young adults between ... annual report on the nation,s health from the U.S. Centers ...
... and surgery is not possible, transplanting stem cells from the patient,s ... this chronic disease. , The procedure has been ... the disease has been shown in 80% of cases, and considerable ... Since August 2008, Hospital Clnic has used this therapy in a ...
... EAST LANSING, Mich. Women are 30 percent less ... than can limit brain damage after a stroke, according ... findings were presented Feb. 19 in San Diego at ... Association and American Stroke Association. , Tissue plasminogen activator, ...
... Nears 187,000 in FebruaryHARRISBURG, Pa., Feb. 19 /PRNewswire-USNewswire/ ... -- also known as CHIP -- has launched ... to better serve Latinos, who are the state,s ... recent study of the uninsured, there are more ...
... 90 Inspected Pennsylvania Facilities Meet Federal StandardsHARRISBURG, Pa., ... released reports today showing that all of the ... quarter of 2008 are operating within the guidelines ... Administration.DEP inspects each of Pennsylvania,s approximately 400 certified ...
Cached Medicine News:Health News:Monroe Hospital: Laughter is Best Medicine for Unwelcome Publicity 2Health News:Obesity, Lack of Insurance Take Toll on Young Americans 2Health News:New therapy with stem cells to treat Crohn's disease 2Health News:New therapy with stem cells to treat Crohn's disease 3Health News:New therapy with stem cells to treat Crohn's disease 4Health News:New therapy with stem cells to treat Crohn's disease 5Health News:Women less likely to receive critical care after a stroke, MSU researchers find 2Health News:CHIP Launches New Web Site Serving Pennsylvania's Fast-Growing Latino Population 2Health News:PA DEP Releases Quarterly Mammography Inspections 2Health News:PA DEP Releases Quarterly Mammography Inspections 3Health News:PA DEP Releases Quarterly Mammography Inspections 4
... Our most popular onsite test! QuickScreen multi-panel ... urine sample, and your choice of any ... multi-panels offer total flexibility for your drug ... the specimen and the built-in timer tells ...
... SureStep™ Drug Screen Tests are available in ... MDMA (Ecstasy). Designed using Microgenics Antibody Technology, ... only point of care immunoassay targeted to ... both MDA and MDEA but no cross-reactivity ...
... The ADC drugs of abuse tests are ... at the SAMHSA recommended cut-off as confirmed by ... result. A more specific alternative method (such as ... a confirmed result. Professional judgment should be applied ...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
Medicine Products: